Modern Africa Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Modern Africa Today.

Press releases published on June 9, 2026

Jun. 9, 2026

Kojo Samwell Asare Highlights Cross-Border Investment Opportunities and the Future of West African Capital Markets

Indeterminate EIN Presswire

Jun. 9, 2026

ExGen Announces $1,000,000 Private Placement

Indeterminate GlobeNewswire

Jun. 9, 2026

Cellectis Receives FDA RMAT Designation for lasme-cel, the First Allogeneic CAR-T Therapy in a Pivotal Trial for Patients with r/r B-ALL

Indeterminate GlobeNewswire

Jun. 9, 2026

Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire

Indeterminate GlobeNewswire

Jun. 9, 2026

Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders

Indeterminate GlobeNewswire

Jun. 9, 2026

Context Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 9, 2026

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jun. 9, 2026

Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN

Indeterminate GlobeNewswire

Jun. 9, 2026

Preparing for the 47-Day Certificate Era with sslTrus CaaS

Indeterminate EIN Presswire

Jun. 9, 2026

AIM ImmunoTech Announces $2.65 Million Financing Priced At-Market under NYSE American Rules

Indeterminate GlobeNewswire

Jun. 9, 2026

Palisade Bio to Present on the Potential of PALI-2108 for Fibrostenotic Crohn’s Disease at New York Academy of Sciences Symposium

Indeterminate GlobeNewswire

Jun. 9, 2026

OneTwoMarkets Reports Continued User Growth and Expanded Market Reach

Indeterminate GlobeNewswire

Jun. 9, 2026

Matisse Pharmaceuticals receives FDA Fast Track Designation for isupartob sodium in sepsis

Indeterminate GlobeNewswire

Jun. 9, 2026

Linnaeus Therapeutics Announces Selection of LNS8801 into the National Institute on Aging Interventions Testing Program

Indeterminate GlobeNewswire

Jun. 9, 2026

Nasus Pharma Announces Positive Results from Preclinical Pharmacokinetic and Safety Study of Intranasal Ondansetron (NS003) 

Indeterminate GlobeNewswire

Jun. 9, 2026

Windward Bio Doses First Patients in Phase 2 SIRIUS COPD Study of Ultra Long-Acting Anti-TSLP Antibody WIN378

Indeterminate GlobeNewswire

Jun. 9, 2026

Vaxart to Participate in BTIG Infectious Disease Day 2026

Indeterminate GlobeNewswire

Jun. 9, 2026

GoldHaven Closes Upsized C$5.75 Million LIFE Financing to Advance Magno and Copeçal Projects

Indeterminate GlobeNewswire

Jun. 9, 2026

Actuate Therapeutics’ Elraglusib Selected for Evaluation in BEACON2 Trial for High-Risk Pediatric Neuroblastoma

Indeterminate GlobeNewswire

Jun. 9, 2026

Corvus Pharmaceuticals Announces Additional Investment in Angel Pharmaceuticals to Advance the Development of Soquelitinib in China

Indeterminate GlobeNewswire